Immunogenicity of a Live-Attenuated Dengue Vaccine Using a Heterologous Prime-Boost Strategy in a Phase 1 Randomized Clinical Trial
Leyi Lin(Walter Reed Army Institute of Research), Stephen J. Thomas(Walter Reed Army Institute of Research), Marvin J. Sklar(Naval Medical Research Command), Naomi Aronson(Uniformed Services University of the Health Sciences), Louis E. Jasper(United States Army Medical Research and Development Command), Gregory D. Gromowski(Walter Reed Army Institute of Research), Timothy P. Endy(SUNY Upstate Medical University), Heather Friberg(Walter Reed Army Institute of Research), Rafael De La Barrera(Walter Reed Army Institute of Research), Kristopher Paolino(Walter Reed National Military Medical Center), Kenneth H. Eckels(Walter Reed Army Institute of Research), Richard G. Jarman(Walter Reed Army Institute of Research), Erica L Sondergaard(Walter Reed Army Institute of Research), Michael Koren(Jacksonville University), Paul B. Keiser(Walter Reed Army Institute of Research), Jeffrey R. Currier(Walter Reed Army Institute of Research)
Cited by 24
Related Papers
A Recombinant Vesicular Stomatitis Virus Ebola Vaccine
|New England Journal of Medicine|2015|390
Invasive Mold Infections Following Combat-related Injuries
|Clinical Infectious Diseases|2012|191
TAK-101 Nanoparticles Induce Gluten-Specific Tolerance in Celiac Disease: A Randomized, Double-Blind, Placebo-Controlled Study
|Gastroenterology|2021|177
Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection
|Annals of Internal Medicine|2020|93